{"parse":{"title":"Extrapyramidal symptoms","pageid":5620134,"revid":844190299,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox\" style=\"width:22em\"><tbody><tr><th colspan=\"2\" style=\"text-align:center;font-size:125%;font-weight:bold;background:#ccc\">Extrapyramidal symptoms</th></tr><tr><th scope=\"row\">Synonyms</th><td>\nExtrapyramidal side effects (EPSE)</td></tr><tr><th scope=\"row\"><a href=\"/wiki/Specialty_(medicine)\" title=\"Specialty (medicine)\">Specialty</a></th><td>\n<a href=\"/wiki/Neurology\" title=\"Neurology\">Neurology</a></td></tr></tbody></table>\n<p><b>Extrapyramidal symptoms</b> (<b>EPS</b>), also known as <b>extrapyramidal side effects</b> (<b>EPSE</b>), are drug-induced movement disorders that include <a href=\"/wiki/Acute_(medicine)\" title=\"Acute (medicine)\">acute</a> and tardive symptoms.  These symptoms include <a href=\"/wiki/Dystonia\" title=\"Dystonia\">dystonia</a> (continuous spasms and muscle contractions), <a href=\"/wiki/Akathisia\" title=\"Akathisia\">akathisia</a> (motor restlessness), <a href=\"/wiki/Parkinsonism\" title=\"Parkinsonism\">parkinsonism</a> (characteristic symptoms such as rigidity), <a href=\"/wiki/Hypokinesia\" title=\"Hypokinesia\">bradykinesia</a> (slowness of movement), <a href=\"/wiki/Tremor\" title=\"Tremor\">tremor</a>, and <a href=\"/wiki/Tardive_dyskinesia\" title=\"Tardive dyskinesia\">tardive dyskinesia</a> (irregular, jerky movements).<sup id=\"cite_ref-ReferenceA_1-0\" class=\"reference\"><a href=\"#cite_note-ReferenceA-1\">&#91;1&#93;</a></sup> Antipsychotics are often discontinued due to inefficacy and intolerable side effects such as extrapyramidal symptoms.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup>\n</p><p>Since it is difficult to measure extrapyramidal symptoms, rating scales are commonly used to assess the severity of movement disorders. The Simpson-Angus Scale (SAS), Barnes Akathisia Rating Scale (BARS), Abnormal Involuntary Movement Scale (AIMS), and Extrapyramidal Symptom Rating Scale (ESRS) are rating scales frequently used for such assessment and are not weighted for diagnostic purposes;<sup id=\"cite_ref-ReferenceA_1-1\" class=\"reference\"><a href=\"#cite_note-ReferenceA-1\">&#91;1&#93;</a></sup> these scales can help physicians weigh the benefit/expected benefit of a medication against the degree of distress which the side effects are causing the patient, aiding in the decision to maintain, reduce, or discontinue the causative medication/s.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Name\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Name</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Causes\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Causes</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Conditions\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Conditions</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Treatment\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Treatment</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#See_also\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#External_links\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Name\">Name</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Extrapyramidal_symptoms&amp;action=edit&amp;section=1\" title=\"Edit section: Name\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The <a href=\"/wiki/Extrapyramidal_system\" title=\"Extrapyramidal system\">extrapyramidal system</a> regulates posture and skeletal muscle tone.  Extrapyramidal symptoms (also called extrapyramidal side effects) get their name because they are symptoms of disorders in this system.\n</p>\n<h2><span class=\"mw-headline\" id=\"Causes\">Causes</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Extrapyramidal_symptoms&amp;action=edit&amp;section=2\" title=\"Edit section: Causes\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Extrapyramidal symptoms are most commonly caused by <a href=\"/wiki/Typical_antipsychotic\" title=\"Typical antipsychotic\">typical antipsychotic</a> drugs that antagonize dopamine D2 receptors.<sup id=\"cite_ref-ReferenceA_1-2\" class=\"reference\"><a href=\"#cite_note-ReferenceA-1\">&#91;1&#93;</a></sup> The most common <a href=\"/wiki/Typical_antipsychotics\" class=\"mw-redirect\" title=\"Typical antipsychotics\">typical antipsychotics</a> associated with EPS are <a href=\"/wiki/Haloperidol\" title=\"Haloperidol\">haloperidol</a> and <a href=\"/wiki/Fluphenazine\" title=\"Fluphenazine\">fluphenazine</a>.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup> Atypical antipsychotics have lower D2 receptor affinity or higher serotonin 5-HT2A receptor affinity which lead to lower rates of EPS.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> However, some research has shown that <a href=\"/wiki/Atypical_antipsychotics\" class=\"mw-redirect\" title=\"Atypical antipsychotics\">atypical antipsychotics</a> are just as likely as conventional antipsychotics to cause EPS.<sup id=\"cite_ref-ReferenceA_1-3\" class=\"reference\"><a href=\"#cite_note-ReferenceA-1\">&#91;1&#93;</a></sup>\n</p><p>Other anti-dopaminergic drugs, like the antiemetic <a href=\"/wiki/Metoclopramide\" title=\"Metoclopramide\">metoclopramide</a>, can also result in extrapyramidal side effects.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> Short and long-term use of antidepressants such as <a href=\"/wiki/Selective_serotonin_reuptake_inhibitors\" class=\"mw-redirect\" title=\"Selective serotonin reuptake inhibitors\">selective serotonin reuptake inhibitors</a> (SSRI), <a href=\"/wiki/Serotonin-norepinephrine_reuptake_inhibitors\" class=\"mw-redirect\" title=\"Serotonin-norepinephrine reuptake inhibitors\">serotonin-norepinephrine reuptake inhibitors</a> (SNRI), and <a href=\"/wiki/Norepinephrine-dopamine_reuptake_inhibitors\" class=\"mw-redirect\" title=\"Norepinephrine-dopamine reuptake inhibitors\">norepinephrine-dopamine reuptake inhibitors</a> (NDRI) have also resulted in EPS.<sup id=\"cite_ref-ReferenceB_6-0\" class=\"reference\"><a href=\"#cite_note-ReferenceB-6\">&#91;6&#93;</a></sup> Specifically, <a href=\"/wiki/Duloxetine\" title=\"Duloxetine\">duloxetine</a>, <a href=\"/wiki/Sertraline\" title=\"Sertraline\">sertraline</a>, <a href=\"/wiki/Escitalopram\" title=\"Escitalopram\">escitalopram</a>, <a href=\"/wiki/Fluoxetine\" title=\"Fluoxetine\">fluoxetine</a>, and <a href=\"/wiki/Bupropion\" title=\"Bupropion\">bupropion</a> have been linked to the induction of EPS.<sup id=\"cite_ref-ReferenceB_6-1\" class=\"reference\"><a href=\"#cite_note-ReferenceB-6\">&#91;6&#93;</a></sup> Other causes of extrapyramidal symptoms can include brain damage and meningitis.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Conditions\">Conditions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Extrapyramidal_symptoms&amp;action=edit&amp;section=3\" title=\"Edit section: Conditions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<ul><li><a href=\"/wiki/Dystonia\" title=\"Dystonia\">Acute dystonic reactions</a>: muscular spasms of neck, jaw, back, extremities, eyes, throat, and tongue; highest risk in young men<sup id=\"cite_ref-ReferenceA_1-4\" class=\"reference\"><a href=\"#cite_note-ReferenceA-1\">&#91;1&#93;</a></sup></li>\n<li><a href=\"/wiki/Akathisia\" title=\"Akathisia\">Akathisia</a>: A feeling of internal motor restlessness that can present as tension, nervousness, or anxiety<sup id=\"cite_ref-ReferenceA_1-5\" class=\"reference\"><a href=\"#cite_note-ReferenceA-1\">&#91;1&#93;</a></sup></li>\n<li><a href=\"/wiki/Pseudoparkinsonism\" class=\"mw-redirect\" title=\"Pseudoparkinsonism\">Pseudoparkinsonism</a>: drug-induced <a href=\"/wiki/Parkinsonism\" title=\"Parkinsonism\">parkinsonism</a> (rigidity, <a href=\"/wiki/Bradykinesia\" class=\"mw-redirect\" title=\"Bradykinesia\">bradykinesia</a>, tremor, masked <a href=\"/wiki/Facies_(medical)\" title=\"Facies (medical)\">facies (medical)</a>, shuffling <a href=\"/wiki/Gait\" title=\"Gait\">gait</a>, stooped posture, <a href=\"/wiki/Sialorrhoea\" class=\"mw-redirect\" title=\"Sialorrhoea\">sialorrhoea</a>, and <a href=\"/wiki/Seborrhoea\" class=\"mw-redirect\" title=\"Seborrhoea\">seborrhoea</a>; greater risk in the elderly).<sup id=\"cite_ref-ReferenceA_1-6\" class=\"reference\"><a href=\"#cite_note-ReferenceA-1\">&#91;1&#93;</a></sup> Although <a href=\"/wiki/Parkinson%27s_disease\" title=\"Parkinson&#39;s disease\">Parkinson's disease</a> is primarily a disease of the <a href=\"/wiki/Nigrostriatal_pathway\" title=\"Nigrostriatal pathway\">nigrostriatal pathway</a> and not the extrapyramidal system, loss of dopaminergic neurons in the <a href=\"/wiki/Substantia_nigra\" title=\"Substantia nigra\">substantia nigra</a> leads to dysregulation of the extrapyramidal system. Since this system regulates posture and skeletal muscle tone, a result is the characteristic <a href=\"/wiki/Bradykinesia\" class=\"mw-redirect\" title=\"Bradykinesia\">bradykinesia</a> of Parkinson's.</li>\n<li><a href=\"/wiki/Tardive_dyskinesia\" title=\"Tardive dyskinesia\">Tardive dyskinesia</a>: involuntary muscle movements in the lower face and distal extremities; this can be a chronic condition associated with long-term use of antipsychotics.<sup id=\"cite_ref-ReferenceA_1-7\" class=\"reference\"><a href=\"#cite_note-ReferenceA-1\">&#91;1&#93;</a></sup></li></ul>\n<h2><span class=\"mw-headline\" id=\"Treatment\">Treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Extrapyramidal_symptoms&amp;action=edit&amp;section=4\" title=\"Edit section: Treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p><a href=\"/wiki/Anticholinergic\" title=\"Anticholinergic\">Anticholinergic</a> drugs are used to control <a href=\"/wiki/Neuroleptic\" class=\"mw-redirect\" title=\"Neuroleptic\">neuroleptic</a>-induced EPS, although <a href=\"/wiki/Akathisia\" title=\"Akathisia\">akathisia</a> may require <a href=\"/wiki/Beta_blocker\" title=\"Beta blocker\">beta blockers</a> or even <a href=\"/wiki/Benzodiazepine\" title=\"Benzodiazepine\">benzodiazepines</a>. If the EPS are induced by an <a href=\"/wiki/Antipsychotic\" title=\"Antipsychotic\">antipsychotic</a>, EPS may be reduced by dose titration or by switching to an <a href=\"/wiki/Atypical_antipsychotic\" title=\"Atypical antipsychotic\">atypical antipsychotic</a>, such as <a href=\"/wiki/Aripiprazole\" title=\"Aripiprazole\">aripiprazole</a>, <a href=\"/wiki/Ziprasidone\" title=\"Ziprasidone\">ziprasidone</a>, <a href=\"/wiki/Quetiapine\" title=\"Quetiapine\">quetiapine</a>, <a href=\"/wiki/Olanzapine\" title=\"Olanzapine\">olanzapine</a>, <a href=\"/wiki/Risperidone\" title=\"Risperidone\">risperidone</a>, or <a href=\"/wiki/Clozapine\" title=\"Clozapine\">clozapine</a>. These medications possess an additional mode of action that is believed to negate their effect on the <a href=\"/wiki/Nigrostriatal\" class=\"mw-redirect\" title=\"Nigrostriatal\">nigrostriatal</a> pathway, which means they are associated with fewer extrapyramidal side-effects than \"conventional\" antipsychotics (<a href=\"/wiki/Chlorpromazine\" title=\"Chlorpromazine\">chlorpromazine</a>, <a href=\"/wiki/Haloperidol\" title=\"Haloperidol\">haloperidol</a>, etc.), although some research has shown that second generation neuroleptics cause EPS at the same rate as the first generation drugs.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>\n</p><p>Commonly used medications for EPS are <a href=\"/wiki/Anticholinergic\" title=\"Anticholinergic\">anticholinergic</a> agents such as <a href=\"/wiki/Benztropine\" class=\"mw-redirect\" title=\"Benztropine\">benztropine</a> (Cogentin), <a href=\"/wiki/Diphenhydramine\" title=\"Diphenhydramine\">diphenhydramine</a> (Benadryl), and <a href=\"/wiki/Trihexyphenidyl\" title=\"Trihexyphenidyl\">trihexyphenidyl</a> (Artane). Another common course of treatment includes <a href=\"/wiki/Dopamine_agonist\" title=\"Dopamine agonist\">dopamine agonist</a> agents such as <a href=\"/wiki/Pramipexole\" title=\"Pramipexole\">pramipexole</a>. These medications reverse the symptoms of extrapyramidal side effects caused by antipsychotics or other drugs that either directly or indirectly inhibit dopaminergic neurotransmission.\n</p><p>Studies are yet to be undertaken on the optimum dosage of the causative drugs to reduce their side effects (extrapyramidal symptoms (EPS)).\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Extrapyramidal_symptoms&amp;action=edit&amp;section=5\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Neuroleptic_malignant_syndrome\" title=\"Neuroleptic malignant syndrome\">Neuroleptic malignant syndrome</a></li>\n<li><a href=\"/wiki/Rabbit_syndrome\" title=\"Rabbit syndrome\">Rabbit syndrome</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Extrapyramidal_symptoms&amp;action=edit&amp;section=6\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-ReferenceA-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceA_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_1-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pierre, JM (2005). \"Extrapyramidal symptoms with atypical antipsychotics: incidence, prevention and management\". <i>Drug Safety</i>. <b>28</b> (3): 191\u2013208. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2165/00002018-200528030-00002\">10.2165/00002018-200528030-00002</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15733025\">15733025</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Safety&amp;rft.atitle=Extrapyramidal+symptoms+with+atypical+antipsychotics%3A+incidence%2C+prevention+and+management&amp;rft.volume=28&amp;rft.issue=3&amp;rft.pages=191-208&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.2165%2F00002018-200528030-00002&amp;rft_id=info%3Apmid%2F15733025&amp;rft.au=Pierre%2C+JM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AExtrapyramidal+symptoms\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Jeffrey A. Lieberman, M.D.; T. Scott Stroup, M.D., M.P.H.; Joseph P. McEvoy, M.D.; Marvin S. Swartz, M.D.; Robert A. Rosenheck, M.D.; Diana O. Perkins, M.D., M.P.H.; Richard S.E. Keefe, Ph.D.; Sonia M. Davis, Dr.P.H.; Clarence E. Davis, Ph.D.; Barry D. Lebowitz, Ph.D.; Joanne Severe, M.S.; John K. Hsiao, M.D. &amp; for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators (September 22, 2005). \"Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia\". <i>N Engl J Med</i>. <b>353</b>: 1209\u20131223. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa051688\">10.1056/NEJMoa051688</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16172203\">16172203</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N+Engl+J+Med&amp;rft.atitle=Effectiveness+of+Antipsychotic+Drugs+in+Patients+with+Chronic+Schizophrenia&amp;rft.volume=353&amp;rft.pages=1209-1223&amp;rft.date=2005-09-22&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa051688&amp;rft_id=info%3Apmid%2F16172203&amp;rft.au=Jeffrey+A.+Lieberman%2C+M.D.&amp;rft.au=T.+Scott+Stroup%2C+M.D.%2C+M.P.H.&amp;rft.au=Joseph+P.+McEvoy%2C+M.D.&amp;rft.au=Marvin+S.+Swartz%2C+M.D.&amp;rft.au=Robert+A.+Rosenheck%2C+M.D.&amp;rft.au=Diana+O.+Perkins%2C+M.D.%2C+M.P.H.&amp;rft.au=Richard+S.E.+Keefe%2C+Ph.D.&amp;rft.au=Sonia+M.+Davis%2C+Dr.P.H.&amp;rft.au=Clarence+E.+Davis%2C+Ph.D.&amp;rft.au=Barry+D.+Lebowitz%2C+Ph.D.&amp;rft.au=Joanne+Severe%2C+M.S.&amp;rft.au=John+K.+Hsiao%2C+M.D.&amp;rft.au=for+the+Clinical+Antipsychotic+Trials+of+Intervention+Effectiveness+%28CATIE%29+Investigators&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AExtrapyramidal+symptoms\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Nevena Divac; Milica Prostran; Igor Jakovcevski &amp; Natasa Cerovac (2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.hindawi.com/journals/bmri/2014/656370/\">\"Second-Generation Antipsychotics and Extrapyramidal Adverse Effects\"</a>. <i>BioMed Research International</i>. <b>2014</b>: 6 pages. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1155/2014/656370\">10.1155/2014/656370</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BioMed+Research+International&amp;rft.atitle=Second-Generation+Antipsychotics+and+Extrapyramidal+Adverse+Effects&amp;rft.volume=2014&amp;rft.pages=6+pages&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1155%2F2014%2F656370&amp;rft.au=Nevena+Divac&amp;rft.au=Milica+Prostran&amp;rft.au=Igor+Jakovcevski&amp;rft.au=Natasa+Cerovac&amp;rft_id=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fbmri%2F2014%2F656370%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AExtrapyramidal+symptoms\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Correll C (2014). \"Mechanism of Action of Antipsychotic Medications\". <i>J Clin Psychiatry</i>. <b>75</b> (9): e23. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4088/jcp.13078tx4c\">10.4088/jcp.13078tx4c</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.atitle=Mechanism+of+Action+of+Antipsychotic+Medications&amp;rft.volume=75&amp;rft.issue=9&amp;rft.pages=e23&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.4088%2Fjcp.13078tx4c&amp;rft.au=Correll+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AExtrapyramidal+symptoms\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Moos, DD.; Hansen, DJ. (October 2008). \"Metoclopramide and Extrapyramidal Symptoms: A Case Report\". <i>Journal of PeriAnesthesia Nursing</i>. <b>23</b> (5): 292\u2013299. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.jopan.2008.07.006\">10.1016/j.jopan.2008.07.006</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18926476\">18926476</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+PeriAnesthesia+Nursing&amp;rft.atitle=Metoclopramide+and+Extrapyramidal+Symptoms%3A+A+Case+Report&amp;rft.volume=23&amp;rft.issue=5&amp;rft.pages=292-299&amp;rft.date=2008-10&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jopan.2008.07.006&amp;rft_id=info%3Apmid%2F18926476&amp;rft.au=Moos%2C+DD.&amp;rft.au=Hansen%2C+DJ.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AExtrapyramidal+symptoms\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReferenceB-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceB_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceB_6-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Madhusoodanan S, Alexeenko L, Sanders R, Brenner R (2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.aacp.com/pdf%2F0810%2F0810ACP_Madhusoodanan.pdf\">\"Extrapyramidal symptoms associated with antidepressants\u2014A review of the literature and an analysis of spontaneous reports\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Annals of Clinical Psychiatry</i>. <b>22</b> (3): 148\u2013156. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20680187\">20680187</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Clinical+Psychiatry&amp;rft.atitle=Extrapyramidal+symptoms+associated+with+antidepressants%E2%80%94A+review+of+the+literature+and+an+analysis+of+spontaneous+reports&amp;rft.volume=22&amp;rft.issue=3&amp;rft.pages=148-156&amp;rft.date=2010&amp;rft_id=info%3Apmid%2F20680187&amp;rft.aulast=Madhusoodanan&amp;rft.aufirst=S&amp;rft.au=Alexeenko%2C+L&amp;rft.au=Sanders%2C+R&amp;rft.au=Brenner%2C+R&amp;rft_id=https%3A%2F%2Fwww.aacp.com%2Fpdf%252F0810%252F0810ACP_Madhusoodanan.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AExtrapyramidal+symptoms\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ori Scott; Simona Hasal &amp; Helly R. Goez (November 2013) [September 10, 2012]. \"Basal Ganglia Injury With Extrapyramidal Presentation: A Complication of Meningococcal Meningitis\". <i>J Child Neurol</i>. <b>28</b>: 1489\u20131492. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/0883073812457463\">10.1177/0883073812457463</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22965562\">22965562</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Child+Neurol&amp;rft.atitle=Basal+Ganglia+Injury+With+Extrapyramidal+Presentation%3A+A+Complication+of+Meningococcal+Meningitis&amp;rft.volume=28&amp;rft.pages=1489-1492&amp;rft.date=2013-11&amp;rft_id=info%3Adoi%2F10.1177%2F0883073812457463&amp;rft_id=info%3Apmid%2F22965562&amp;rft.au=Ori+Scott&amp;rft.au=Simona+Hasal&amp;rft.au=Helly+R.+Goez&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AExtrapyramidal+symptoms\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">P. Adnet; P. Lestavel &amp; R. Krivosic\u2010Horber (2000). \"Neuroleptic malignant syndrome\". <i>Br. J. Anaesth</i>. <b>85</b> (1): 129\u2013135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/bja/85.1.129\">10.1093/bja/85.1.129</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Br.+J.+Anaesth.&amp;rft.atitle=Neuroleptic+malignant+syndrome&amp;rft.volume=85&amp;rft.issue=1&amp;rft.pages=129-135&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1093%2Fbja%2F85.1.129&amp;rft.au=P.+Adnet&amp;rft.au=P.+Lestavel&amp;rft.au=R.+Krivosic%E2%80%90Horber&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AExtrapyramidal+symptoms\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Kermit Cole (March 26, 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.madinamerica.com/2012/03/second-generation-antipsychotics-no-better-than-first-but-education-lags/\">\"Second-Generation Antipsychotics Just as Likely as Older Drugs to Cause EPS\"</a>. <i>Mad in America</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Mad+in+America&amp;rft.atitle=Second-Generation+Antipsychotics+Just+as+Likely+as+Older+Drugs+to+Cause+EPS&amp;rft.date=2012-03-26&amp;rft.au=Kermit+Cole&amp;rft_id=https%3A%2F%2Fwww.madinamerica.com%2F2012%2F03%2Fsecond-generation-antipsychotics-no-better-than-first-but-education-lags%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AExtrapyramidal+symptoms\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Michael J. Peluso; Sh\u00f4n W. Lewis; Thomas R. E. Barnes; Peter B. Jones (2012). <a rel=\"nofollow\" class=\"external text\" href=\"http://bjp.rcpsych.org/content/200/5/387.long\">\"Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs\"</a>. <i>The British Journal of Psychiatry</i>. <b>200</b> (5): 387\u201392. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1192/bjp.bp.111.101485\">10.1192/bjp.bp.111.101485</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22442101\">22442101</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+British+Journal+of+Psychiatry&amp;rft.atitle=Extrapyramidal+motor+side-effects+of+first-+and+second-generation+antipsychotic+drugs&amp;rft.volume=200&amp;rft.issue=5&amp;rft.pages=387-92&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1192%2Fbjp.bp.111.101485&amp;rft_id=info%3Apmid%2F22442101&amp;rft.au=Michael+J.+Peluso&amp;rft.au=Sh%C3%B4n+W.+Lewis&amp;rft.au=Thomas+R.+E.+Barnes&amp;rft.au=Peter+B.+Jones&amp;rft_id=http%3A%2F%2Fbjp.rcpsych.org%2Fcontent%2F200%2F5%2F387.long&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AExtrapyramidal+symptoms\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Extrapyramidal_symptoms&amp;action=edit&amp;section=7\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"infobox\" style=\"width:22em;width:100%; margin:0 0 0.5em 0;\"><tbody><tr><th scope=\"row\">Classification</th><td style=\"text-align:left;\">\n<div style=\"position:relative; float:right; font-size:0.8em;\"><a href=\"https://www.wikidata.org/wiki/Q1385411\" class=\"extiw\" title=\"d:Q1385411\">D</a></div><div class=\"hlist hlist-separated\" style=\"text-align:left;\"><ul><li><b><a href=\"/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems\" title=\"International Statistical Classification of Diseases and Related Health Problems\">ICD</a>-<a href=\"/wiki/List_of_ICD-9_codes\" title=\"List of ICD-9 codes\">9-CM</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.icd9data.com/getICD9Code.ashx?icd9=333.90\">333.90</a></li></ul></div></td></tr></tbody></table>\n\n<!-- \nNewPP limit report\nParsed by mw2277\nCached time: 20180918215819\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.268 seconds\nReal time usage: 0.446 seconds\nPreprocessor visited node count: 1112/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 24239/2097152 bytes\nTemplate argument size: 593/2097152 bytes\nHighest expansion depth: 9/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 15120/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.136/10.000 seconds\nLua memory usage: 4.75 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  405.705      1 -total\n 35.32%  143.293      2 Template:Infobox\n 35.23%  142.915      1 Template:Infobox_medical_condition_(new)\n 34.06%  138.171      1 Template:Reflist\n 27.63%  112.113      1 Template:Medical_resources\n 25.40%  103.045      9 Template:Cite_journal\n  5.85%   23.723      4 Template:Main_other\n  5.77%   23.393      2 Template:Hlist\n  1.40%    5.661      1 Template:Str_find\n  1.31%    5.302      1 Template:Cite_web\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:5620134-0!canonical and timestamp 20180918215818 and revision id 844190299\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%A3%D8%B9%D8%B1%D8%A7%D8%B6_%D8%AE%D8%A7%D8%B1%D8%AC_%D8%A7%D9%84%D8%B3%D8%A8%D9%8A%D9%84_%D8%A7%D9%84%D9%87%D8%B1%D9%85%D9%8A","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0623\u0639\u0631\u0627\u0636 \u062e\u0627\u0631\u062c \u0627\u0644\u0633\u0628\u064a\u0644 \u0627\u0644\u0647\u0631\u0645\u064a"},{"lang":"de","url":"https://de.wikipedia.org/wiki/Extrapyramidales_Syndrom","langname":"German","autonym":"Deutsch","*":"Extrapyramidales Syndrom"},{"lang":"fa","url":"https://fa.wikipedia.org/wiki/%D8%B9%D9%88%D8%A7%D8%B1%D8%B6_%D8%AE%D8%A7%D8%B1%D8%AC_%D9%87%D8%B1%D9%85%DB%8C","langname":"Persian","autonym":"\u0641\u0627\u0631\u0633\u06cc","*":"\u0639\u0648\u0627\u0631\u0636 \u062e\u0627\u0631\u062c \u0647\u0631\u0645\u06cc"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Syndrome_extrapyramidal","langname":"French","autonym":"fran\u00e7ais","*":"Syndrome extrapyramidal"},{"lang":"ko","url":"https://ko.wikipedia.org/wiki/%EC%B6%94%EC%B2%B4%EC%99%B8%EB%A1%9C_%EC%A6%9D%EC%83%81","langname":"Korean","autonym":"\ud55c\uad6d\uc5b4","*":"\ucd94\uccb4\uc678\ub85c \uc99d\uc0c1"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E9%8C%90%E4%BD%93%E5%A4%96%E8%B7%AF%E7%97%87%E7%8A%B6","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u9310\u4f53\u5916\u8def\u75c7\u72b6"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Zesp%C3%B3%C5%82_pozapiramidowy","langname":"Polish","autonym":"polski","*":"Zesp\u00f3\u0142 pozapiramidowy"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/%D0%AD%D0%BA%D1%81%D1%82%D1%80%D0%B0%D0%BF%D0%B8%D1%80%D0%B0%D0%BC%D0%B8%D0%B4%D0%BD%D1%8B%D0%B5_%D1%80%D0%B0%D1%81%D1%81%D1%82%D1%80%D0%BE%D0%B9%D1%81%D1%82%D0%B2%D0%B0","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"\u042d\u043a\u0441\u0442\u0440\u0430\u043f\u0438\u0440\u0430\u043c\u0438\u0434\u043d\u044b\u0435 \u0440\u0430\u0441\u0441\u0442\u0440\u043e\u0439\u0441\u0442\u0432\u0430"},{"lang":"fi","url":"https://fi.wikipedia.org/wiki/Ekstrapyramidaalioire","langname":"Finnish","autonym":"suomi","*":"Ekstrapyramidaalioire"},{"lang":"sv","url":"https://sv.wikipedia.org/wiki/Extrapyramidala_bieffekter","langname":"Swedish","autonym":"svenska","*":"Extrapyramidala bieffekter"},{"lang":"zh","url":"https://zh.wikipedia.org/wiki/%E9%8C%90%E9%AB%94%E5%A4%96%E7%97%87%E5%80%99%E7%BE%A4","langname":"Chinese","autonym":"\u4e2d\u6587","*":"\u9310\u9ad4\u5916\u75c7\u5019\u7fa4"}],"categories":[{"sortkey":"","hidden":"","*":"Infobox_medical_condition_(new)"},{"sortkey":"*","*":"Antipsychotics"},{"sortkey":"","*":"Extrapyramidal_and_movement_disorders"},{"sortkey":"","*":"Syndromes"}],"links":[{"ns":0,"exists":"","*":"Acute (medicine)"},{"ns":0,"exists":"","*":"Akathisia"},{"ns":0,"exists":"","*":"Anticholinergic"},{"ns":0,"exists":"","*":"Antipsychotic"},{"ns":0,"exists":"","*":"Aripiprazole"},{"ns":0,"exists":"","*":"Atypical antipsychotic"},{"ns":0,"exists":"","*":"Atypical antipsychotics"},{"ns":0,"exists":"","*":"Benzodiazepine"},{"ns":0,"exists":"","*":"Benztropine"},{"ns":0,"exists":"","*":"Beta blocker"},{"ns":0,"exists":"","*":"Bradykinesia"},{"ns":0,"exists":"","*":"Bupropion"},{"ns":0,"exists":"","*":"Chlorpromazine"},{"ns":0,"exists":"","*":"Clozapine"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Diphenhydramine"},{"ns":0,"exists":"","*":"Dopamine agonist"},{"ns":0,"exists":"","*":"Duloxetine"},{"ns":0,"exists":"","*":"Dystonia"},{"ns":0,"exists":"","*":"Escitalopram"},{"ns":0,"exists":"","*":"Extrapyramidal system"},{"ns":0,"exists":"","*":"Facies (medical)"},{"ns":0,"exists":"","*":"Fluoxetine"},{"ns":0,"exists":"","*":"Fluphenazine"},{"ns":0,"exists":"","*":"Gait"},{"ns":0,"exists":"","*":"Haloperidol"},{"ns":0,"exists":"","*":"Hypokinesia"},{"ns":0,"exists":"","*":"International Statistical Classification of Diseases and Related Health Problems"},{"ns":0,"exists":"","*":"List of ICD-9 codes"},{"ns":0,"exists":"","*":"Metoclopramide"},{"ns":0,"exists":"","*":"Neuroleptic"},{"ns":0,"exists":"","*":"Neuroleptic malignant syndrome"},{"ns":0,"exists":"","*":"Neurology"},{"ns":0,"exists":"","*":"Nigrostriatal"},{"ns":0,"exists":"","*":"Nigrostriatal pathway"},{"ns":0,"exists":"","*":"Norepinephrine-dopamine reuptake inhibitors"},{"ns":0,"exists":"","*":"Olanzapine"},{"ns":0,"exists":"","*":"Parkinson's disease"},{"ns":0,"exists":"","*":"Parkinsonism"},{"ns":0,"exists":"","*":"Pramipexole"},{"ns":0,"exists":"","*":"Pseudoparkinsonism"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Quetiapine"},{"ns":0,"exists":"","*":"Rabbit syndrome"},{"ns":0,"exists":"","*":"Risperidone"},{"ns":0,"exists":"","*":"Seborrhoea"},{"ns":0,"exists":"","*":"Selective serotonin reuptake inhibitors"},{"ns":0,"exists":"","*":"Serotonin-norepinephrine reuptake inhibitors"},{"ns":0,"exists":"","*":"Sertraline"},{"ns":0,"exists":"","*":"Sialorrhoea"},{"ns":0,"exists":"","*":"Specialty (medicine)"},{"ns":0,"exists":"","*":"Substantia nigra"},{"ns":0,"exists":"","*":"Tardive dyskinesia"},{"ns":0,"exists":"","*":"Tremor"},{"ns":0,"exists":"","*":"Trihexyphenidyl"},{"ns":0,"exists":"","*":"Typical antipsychotic"},{"ns":0,"exists":"","*":"Typical antipsychotics"},{"ns":0,"exists":"","*":"Ziprasidone"}],"templates":[{"ns":10,"exists":"","*":"Template:Infobox medical condition (new)"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Medical resources"},{"ns":10,"exists":"","*":"Template:Hlist"},{"ns":10,"exists":"","*":"Template:ICD9"},{"ns":10,"exists":"","*":"Template:Str find"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:String2"},{"ns":828,"exists":"","*":"Module:WikidataIB/sandbox"},{"ns":828,"exists":"","*":"Module:Complex date"},{"ns":828,"exists":"","*":"Module:I18n/complex date"},{"ns":828,"exists":"","*":"Module:Ordinal"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Roman"},{"ns":828,"exists":"","*":"Module:ISOdate"},{"ns":828,"exists":"","*":"Module:DateI18n"},{"ns":828,"exists":"","*":"Module:I18n/date"},{"ns":828,"exists":"","*":"Module:Calendar"},{"ns":828,"exists":"","*":"Module:I18n"},{"ns":828,"*":"Module:WikidataIB/i18n"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:String"}],"images":[],"externallinks":["//doi.org/10.2165/00002018-200528030-00002","//www.ncbi.nlm.nih.gov/pubmed/15733025","//doi.org/10.1056/NEJMoa051688","//www.ncbi.nlm.nih.gov/pubmed/16172203","http://www.hindawi.com/journals/bmri/2014/656370/","//doi.org/10.1155/2014/656370","//doi.org/10.4088/jcp.13078tx4c","//doi.org/10.1016/j.jopan.2008.07.006","//www.ncbi.nlm.nih.gov/pubmed/18926476","https://www.aacp.com/pdf%2F0810%2F0810ACP_Madhusoodanan.pdf","//www.ncbi.nlm.nih.gov/pubmed/20680187","//doi.org/10.1177/0883073812457463","//www.ncbi.nlm.nih.gov/pubmed/22965562","//doi.org/10.1093/bja/85.1.129","https://www.madinamerica.com/2012/03/second-generation-antipsychotics-no-better-than-first-but-education-lags/","http://bjp.rcpsych.org/content/200/5/387.long","//doi.org/10.1192/bjp.bp.111.101485","//www.ncbi.nlm.nih.gov/pubmed/22442101","http://www.icd9data.com/getICD9Code.ashx?icd9=333.90"],"sections":[{"toclevel":1,"level":"2","line":"Name","number":"1","index":"1","fromtitle":"Extrapyramidal_symptoms","byteoffset":2841,"anchor":"Name"},{"toclevel":1,"level":"2","line":"Causes","number":"2","index":"2","fromtitle":"Extrapyramidal_symptoms","byteoffset":3062,"anchor":"Causes"},{"toclevel":2,"level":"3","line":"Conditions","number":"2.1","index":"3","fromtitle":"Extrapyramidal_symptoms","byteoffset":6026,"anchor":"Conditions"},{"toclevel":1,"level":"2","line":"Treatment","number":"3","index":"4","fromtitle":"Extrapyramidal_symptoms","byteoffset":7158,"anchor":"Treatment"},{"toclevel":1,"level":"2","line":"See also","number":"4","index":"5","fromtitle":"Extrapyramidal_symptoms","byteoffset":9248,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"6","fromtitle":"Extrapyramidal_symptoms","byteoffset":9322,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"6","index":"7","fromtitle":"Extrapyramidal_symptoms","byteoffset":9350,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Extrapyramidal symptoms","iwlinks":[{"prefix":"d","url":"https://www.wikidata.org/wiki/Q1385411","*":"d:Q1385411"}],"properties":[{"name":"wikibase_item","*":"Q1385411"}]}}